Search by Drug Name or NDC

    NDC 11822-0710-01 Daytime Severe Cold and Flu Relief 325; 10; 200; 5 mg/15mL; mg/15mL; mg/15mL; mg/15mL Details

    Daytime Severe Cold and Flu Relief 325; 10; 200; 5 mg/15mL; mg/15mL; mg/15mL; mg/15mL

    Daytime Severe Cold and Flu Relief is a ORAL SOLUTION in the HUMAN OTC DRUG category. It is labeled and distributed by Rite Aid Corporation. The primary component is ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE.

    Product Information

    NDC 11822-0710
    Product ID 11822-0710_f777d730-164e-4b07-83bf-4a4c61ffc08f
    Associated GPIs
    GCN Sequence Number n/a
    GCN Sequence Number Description n/a
    HIC3 n/a
    HIC3 Description n/a
    GCN n/a
    HICL Sequence Number n/a
    HICL Sequence Number Description n/a
    Brand/Generic n/a
    Proprietary Name Daytime Severe Cold and Flu Relief
    Proprietary Name Suffix n/a
    Non-Proprietary Name acetaminophen, dextromethorphan hbr, guaifenesin, phenylephrine hcl
    Product Type HUMAN OTC DRUG
    Dosage Form SOLUTION
    Route ORAL
    Active Ingredient Strength 325; 10; 200; 5
    Active Ingredient Units mg/15mL; mg/15mL; mg/15mL; mg/15mL
    Substance Name ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE
    Labeler Name Rite Aid Corporation
    Pharmaceutical Class Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC
    DEA Schedule n/a
    Marketing Category OTC MONOGRAPH FINAL
    Application Number part341
    Listing Certified Through 2024-12-31

    Package

    NDC 11822-0710-01 (11822071001)

    NDC Package Code 11822-0710-1
    Billing NDC 11822071001
    Package 355 mL in 1 BOTTLE (11822-0710-1)
    Marketing Start Date 2014-06-18
    NDC Exclude Flag N
    Pricing Information N/A

    Standard Product Labeling (SPL)/Prescribing Information SPL 8d41defe-8120-4cbb-b42e-c805cc5a794b Details

    Revised: 7/2022